Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma

Open access

Abstract

Senescent cells may promote tumour progression through the activation of a senescence-associated secretory phenotype (SASP), whether these cells are capable of initiating tumourigenesis in vivo is not known. Expression of oncogenic β-catenin in Sox2+ young adult pituitary stem cells leads to formation of clusters of stem cells and induction of tumours resembling human adamantinomatous craniopharyngioma (ACP), derived from Sox2− cells in a paracrine manner. Here, we uncover the mechanisms underlying this paracrine tumourigenesis. We show that expression of oncogenic β-catenin in Hesx1+ embryonic precursors also results in stem cell clusters and paracrine tumours. We reveal that human and mouse clusters are analogous and share a common signature of senescence and SASP. Finally, we show that mice with reduced senescence and SASP responses exhibit decreased tumour-inducing potential. Together, we provide evidence that senescence and a stem cell-associated SASP drive cell transformation and tumour initiation in vivo in an age-dependent fashion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-01992-5

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Tumours in the Hesx1Cre/+;Ctnnb1lox(ex3)/+;R26YFP/+ mice form non-cell autonomously after a latency period. a Brightfield and epifluorescence images of 18.5 dpc pituitaries. Note that most of the anterior lobe (al), but not the posterior (pl), is fluorescent in both the Hesx1Cre/+;R26YFP/+ control and Hesx1Cre/+;Ctnnb1lox(ex3)/+;R26YFP/+ pituitaries. The mutant pre-tumoural pituitary is enlarged relative to controls. Scale bar: 1 mm. b Brightfield and epifluorescence pictures of a pre-tumoural pituitary and tumours in Hesx1Cre/+;Ctnnb1lox(ex3)/+;R26YFP/+ mutant mice at 5, 20 and 35 weeks of age. Most of the tumour cells are not fluorescent and the YFP+ population (white arrow) is displaced to the periphery of the growing tumour mass (white asterisks). Scale bar: 5 mm. c Histological characterisation of pre-tumoural pituitaries and developing tumours from 18.5 dpc to 35 weeks postnatally. At 18.5 dpc, most of the embryonic pituitary is comprised of YFP+ cells (revealed with anti-GFP immunostaining), but there are islands of YFP− cells (DAPI+ areas). Abundant Ki67+ cells are distributed throughout the pituitary at this stage. At 5 weeks of age, the pre-tumoural pituitary remains mostly quiescent with very few Ki67+ cells. Note the presence of a dorsal region resembling the normal pituitary tissue of the anterior lobe (al) and a ventral part where YFP− and YFP+ cells are intermingled. The boundary between dorsal and ventral regions is indicated with a dashed line. At 20 weeks, the YFP− population contains abundant Ki67+ cells and has expanded dramatically (white asterisks) displacing the mostly quiescent YFP+ cells to the periphery. Around 35 weeks, mutant mice reach a humane end-point and tumours are mostly YFP− (asterisk). Note that some YFP+ cells are observed in the periphery (white arrow). Immunohistochemistry against synaptophysin shows that whilst the anterior lobe cells (al) are positive, tumours do not express this endocrine marker (black asterisk). Immunostaining against β-catenin showing the presence of cell groups (clusters, white arrows) with nucleo-cytoplasmic accumulation of β-catenin mostly at 18.5 dpc and 5 weeks of age. Subsequently, most of the tumour cells accumulate β-catenin (white asterisk). Results are representative of experiments conducted in at least three different mice for each stage. Scale bars: 100 μm
Fig. 1 Tumours in the Hesx1Cre/+;Ctnnb1lox(ex3)/+;R26YFP/+ mice form non-cell autonomously after a latency period. a Brightfield and epifluorescence images of 18.5 dpc pituitaries. Note that most of the anterior lobe (al), but not the posterior (pl), is fluorescent in both the Hesx1Cre/+;R26YFP/+ control and Hesx1Cre/+;Ctnnb1lox(ex3)/+;R26YFP/+ pituitaries. The mutant pre-tumoural pituitary is enlarged relative to controls. Scale bar: 1 mm. b Brightfield and epifluorescence pictures of a pre-tumoural pituitary and tumours in Hesx1Cre/+;Ctnnb1lox(ex3)/+;R26YFP/+ mutant mice at 5, 20 and 35 weeks of age. Most of the tumour cells are not fluorescent and the YFP+ population (white arrow) is displaced to the periphery of the growing tumour mass (white asterisks). Scale bar: 5 mm. c Histological characterisation of pre-tumoural pituitaries and developing tumours from 18.5 dpc to 35 weeks postnatally. At 18.5 dpc, most of the embryonic pituitary is comprised of YFP+ cells (revealed with anti-GFP immunostaining), but there are islands of YFP− cells (DAPI+ areas). Abundant Ki67+ cells are distributed throughout the pituitary at this stage. At 5 weeks of age, the pre-tumoural pituitary remains mostly quiescent with very few Ki67+ cells. Note the presence of a dorsal region resembling the normal pituitary tissue of the anterior lobe (al) and a ventral part where YFP− and YFP+ cells are intermingled. The boundary between dorsal and ventral regions is indicated with a dashed line. At 20 weeks, the YFP− population contains abundant Ki67+ cells and has expanded dramatically (white asterisks) displacing the mostly quiescent YFP+ cells to the periphery. Around 35 weeks, mutant mice reach a humane end-point and tumours are mostly YFP− (asterisk). Note that some YFP+ cells are observed in the periphery (white arrow). Immunohistochemistry against synaptophysin shows that whilst the anterior lobe cells (al) are positive, tumours do not express this endocrine marker (black asterisk). Immunostaining against β-catenin showing the presence of cell groups (clusters, white arrows) with nucleo-cytoplasmic accumulation of β-catenin mostly at 18.5 dpc and 5 weeks of age. Subsequently, most of the tumour cells accumulate β-catenin (white asterisk). Results are representative of experiments conducted in at least three different mice for each stage. Scale bars: 100 μmCC BY · PubMed Central
Fig. 2 β-catenin-accumulating cluster cells in mouse and human ACP express senescence markers. Double immunostaining on histological sections of Hesx1Cre/+;Ctnnb1lox(ex3)/+ pre-tumoural pituitaries at 18.5 dpc (a) and human ACP tumours (b). Note that cluster cells (arrows) express lysosomal enzymes such as GLB1, encoding senescence-associated β-galactosidase, the cell cycle regulators p21 and p53, as well as the DNA damage and DNA damage response markers gamma histone 2AX and phospho-DNA-PKcs, respectively. Results are representative from experiments conducted in six to eight mice and 23 human ACP tumours. Normal brain was used as negative control. Scale bars: a 50 μm; b 100 μm
Fig. 2 β-catenin-accumulating cluster cells in mouse and human ACP express senescence markers. Double immunostaining on histological sections of Hesx1Cre/+;Ctnnb1lox(ex3)/+ pre-tumoural pituitaries at 18.5 dpc (a) and human ACP tumours (b). Note that cluster cells (arrows) express lysosomal enzymes such as GLB1, encoding senescence-associated β-galactosidase, the cell cycle regulators p21 and p53, as well as the DNA damage and DNA damage response markers gamma histone 2AX and phospho-DNA-PKcs, respectively. Results are representative from experiments conducted in six to eight mice and 23 human ACP tumours. Normal brain was used as negative control. Scale bars: a 50 μm; b 100 μmCC BY · PubMed Central
Fig. 3 Cluster cells show activation of the NFκB pathway. Double immunostaining on histological sections of Hesx1Cre/+;Ctnnb1lox(ex3)/+ pre-tumoural pituitaries at 18.5 dpc (a) and human ACP tumours (b). Phospho-IκBα, a readout of activated NFκB pathway, as well as RELA and NEMO, two components of this pathway, are expressed in cluster cells (white arrows). Results are representative of experiments conducted in four to six mice. Scale bar: a 50 μm; b 100 μm
Fig. 3 Cluster cells show activation of the NFκB pathway. Double immunostaining on histological sections of Hesx1Cre/+;Ctnnb1lox(ex3)/+ pre-tumoural pituitaries at 18.5 dpc (a) and human ACP tumours (b). Phospho-IκBα, a readout of activated NFκB pathway, as well as RELA and NEMO, two components of this pathway, are expressed in cluster cells (white arrows). Results are representative of experiments conducted in four to six mice. Scale bar: a 50 μm; b 100 μmCC BY · PubMed Central
Fig. 4 Tissue microenvironment changes in the pre-tumoural pituitary of Hesx1Cre/+; Ctnnb1lox(ex3)/+ mutants. a Immunostaining against endomucin (EMCN), fibronectin and laminin revealing changes in the parenchyma of the pre-tumoural pituitary at 18.5 dpc. Scale bar: 100 μm. b Mutually exclusive staining of YFP+ (detected with an anti-GFP antibody) and EMCN+ cells. Note the presence of YFP+ cells (arrows) surrounding a population of EMCN+ cells. Scale bar: 100 μm. c Triple immunostaining showing the co-expression of EMCN and SOX9 in large group of cells around the β-catenin-accumulating clusters (arrows). Results are representative of experiments conducted in six mice. Scale bar: 100 μm
Fig. 4 Tissue microenvironment changes in the pre-tumoural pituitary of Hesx1Cre/+; Ctnnb1lox(ex3)/+ mutants. a Immunostaining against endomucin (EMCN), fibronectin and laminin revealing changes in the parenchyma of the pre-tumoural pituitary at 18.5 dpc. Scale bar: 100 μm. b Mutually exclusive staining of YFP+ (detected with an anti-GFP antibody) and EMCN+ cells. Note the presence of YFP+ cells (arrows) surrounding a population of EMCN+ cells. Scale bar: 100 μm. c Triple immunostaining showing the co-expression of EMCN and SOX9 in large group of cells around the β-catenin-accumulating clusters (arrows). Results are representative of experiments conducted in six mice. Scale bar: 100 μmCC BY · PubMed Central
Fig. 5 Mouse and human β-catenin-accumulating clusters share a common signature of senescence and SASP. a–d Gene set enrichment analysis (GSEA) (a, c) revealing that clusters from both mouse models, the Hesx1Cre/+;Ctnnb1lox(ex3)/+ and Sox2CrERT2e/+;Ctnnb1lox(ex3)/+;R26YFP/+, show a molecular signature of oncogene-induced senescence (OIS) and senescence-associated secretory phenotype (SASP). qRT-PCR analysis showing the upregulation of several senescence and SASP factors in both mouse models (b, d). Bars in b and d represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test. e Several cytokines are upregulated in the Hesx1Cre/+;Ctnnb1lox(ex3)/+ mutant relative to the Hesx1+/+;Ctnnb1lox(ex3)/+ control pituitaries as measured in a mouse cytokine antibody array. f Gene set enrichment analysis (GSEA) demonstrating that laser-capture micro-dissected human clusters show a molecular signature of oncogene-induced senescence (OIS) and senescence-associated secretory phenotype (SASP). g Hierarchical clustering analysis of RNA-data sets from cluster and non-cluster cell populations indicating coherent grouping between specific cell compartments. h, i GSEA of the top 100 or 500 most upregulated genes in human clusters and the whole transcriptome of mouse clusters from both models demonstrating a common molecular signature
Fig. 5 Mouse and human β-catenin-accumulating clusters share a common signature of senescence and SASP. a–d Gene set enrichment analysis (GSEA) (a, c) revealing that clusters from both mouse models, the Hesx1Cre/+;Ctnnb1lox(ex3)/+ and Sox2CrERT2e/+;Ctnnb1lox(ex3)/+;R26YFP/+, show a molecular signature of oncogene-induced senescence (OIS) and senescence-associated secretory phenotype (SASP). qRT-PCR analysis showing the upregulation of several senescence and SASP factors in both mouse models (b, d). Bars in b and d represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test. e Several cytokines are upregulated in the Hesx1Cre/+;Ctnnb1lox(ex3)/+ mutant relative to the Hesx1+/+;Ctnnb1lox(ex3)/+ control pituitaries as measured in a mouse cytokine antibody array. f Gene set enrichment analysis (GSEA) demonstrating that laser-capture micro-dissected human clusters show a molecular signature of oncogene-induced senescence (OIS) and senescence-associated secretory phenotype (SASP). g Hierarchical clustering analysis of RNA-data sets from cluster and non-cluster cell populations indicating coherent grouping between specific cell compartments. h, i GSEA of the top 100 or 500 most upregulated genes in human clusters and the whole transcriptome of mouse clusters from both models demonstrating a common molecular signatureCC BY · PubMed Central
Fig. 6 Aged Sox2+ stem cells generate β-catenin-accumulating cell clusters with reduced senescence and SASP responses. a Schematic diagram of the experimental designs. Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ and Sox2CreERT2/+;R26YFP/+ mice were tamoxifen induced at either 1 or 6 month of age and the anterior pituitary collected 4 weeks post induction and processed for histological and molecular analysis of YFP+ cells isolated by FACS (n = 8 mice per group). b Double immunostaining on histological sections of Sox2CreERT2/+; Ctnnb1lox(ex3)/+; R26YFP/+ pituitaries revealing the presence of β-catenin-accumulating cell clusters positive for p21, but not for Ki67. Scale bar: 100 µm. c Quantitative analysis showing a significant higher Ki67 proliferation index in non-cluster cells in Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ tumoural relative to Sox2CreERT2/+;R26YFP/+ control pituitaries in tamoxifen-induced mice at 1 month (black asterisk), but not at 6 months. Increased proliferation index is also observed in non-cluster cells in Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ pituitaries of mice induced at 1 month relative to those induced at 6 months (red asterisk). d qRT-PCR analysis showing the upregulation of the WNT pathway target genes Axin2 and Lef1, as well as of several senescence and SASP factors in the Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ mutant pituitaries relative to the Sox2CreERT2/+; R26YFP/+ controls. e qRT analysis showing the relative expression of several senescence and SASP factors in Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ mice tamoxifen induced at either 1 (young) or 6 (older) months of age. The expression of several senescent and SASP factors is significantly reduced in the older compared with the young mice. Bars in c, d and e represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test
Fig. 6 Aged Sox2+ stem cells generate β-catenin-accumulating cell clusters with reduced senescence and SASP responses. a Schematic diagram of the experimental designs. Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ and Sox2CreERT2/+;R26YFP/+ mice were tamoxifen induced at either 1 or 6 month of age and the anterior pituitary collected 4 weeks post induction and processed for histological and molecular analysis of YFP+ cells isolated by FACS (n = 8 mice per group). b Double immunostaining on histological sections of Sox2CreERT2/+; Ctnnb1lox(ex3)/+; R26YFP/+ pituitaries revealing the presence of β-catenin-accumulating cell clusters positive for p21, but not for Ki67. Scale bar: 100 µm. c Quantitative analysis showing a significant higher Ki67 proliferation index in non-cluster cells in Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ tumoural relative to Sox2CreERT2/+;R26YFP/+ control pituitaries in tamoxifen-induced mice at 1 month (black asterisk), but not at 6 months. Increased proliferation index is also observed in non-cluster cells in Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ pituitaries of mice induced at 1 month relative to those induced at 6 months (red asterisk). d qRT-PCR analysis showing the upregulation of the WNT pathway target genes Axin2 and Lef1, as well as of several senescence and SASP factors in the Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ mutant pituitaries relative to the Sox2CreERT2/+; R26YFP/+ controls. e qRT analysis showing the relative expression of several senescence and SASP factors in Sox2CreERT2/+;Ctnnb1lox(ex3)/+;R26YFP/+ mice tamoxifen induced at either 1 (young) or 6 (older) months of age. The expression of several senescent and SASP factors is significantly reduced in the older compared with the young mice. Bars in c, d and e represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t testCC BY · PubMed Central
Fig. 7 Deletion of the tumour suppressor Apc results in β-catenin-accumulating senescent clusters with reduced SASP. a Brightfield and haematoxylin–eosin pictures of wild-type and Hesx1Cre/+;Apcfl/fl pituitaries, and Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitary tumours. Note that the Apc-deficient pituitary is enlarged but no tumours are apparent and it is histologically normal. The age of the mice is indicated in weeks. Scale bar: 1 mm. b Double immunostaining revealing the expression of p21, phospho-IκBα and phospho-DNA-PKcs in the β-catenin-accumulating clusters, indicating cell cycle inhibition and activation of the NFκB and DNA damage response pathways, in both Hesx1Cre/+;Apcfl/fl and Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries at 18.5 dpc. Note that the clusters are smaller in the Hesx1Cre/+;Apcfl/fl compared with the Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries. Scale bar: 50 μm. c qRT-PCR analysis showing the relative expression of several genes in Hesx1Cre/+;Apcfl/fl relative to Hesx1Cre/+; Ctnnb1lox(ex3)/+ pituitaries at 18.5 dpc. The expression of the WNT pathway targets Axin2 and Lef1 are similar between the two genotypes, but several senescence and SASP factors show reduced expression levels in the Hesx1Cre/+;Apcfl/fl compared with the Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries. Bars represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. *p < 0.05, **p < 0.01, Student’s t test. d In situ hybridisation on histological sections of embryos at 14.5 dpc showing the expression of Axin2 in small cell clusters and very reduced or absent detection of Bmp4, Fgf3 and Shh in the Apc-deficient pituitaries. Scale bar: 100 μm. e Triple immunostaining revealing the expression of β-catenin, SOX9 and EMCN. Note that the large areas of EMCN+;SOX9+ cells surrounding the β-catenin-accumulating clusters are not present in the Hesx1Cre/+;Apcfl/fl pituitaries. Scale bar: 50 μm. f Quantification of the EMCN+ areas demonstrating that wild-type and Apc-deficient pituitaries show similar levels, which are significantly increased in the Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries. Bars represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. ***p < 0.001, one-way ANOVA. All results are representative of at least three biological replicates
Fig. 7 Deletion of the tumour suppressor Apc results in β-catenin-accumulating senescent clusters with reduced SASP. a Brightfield and haematoxylin–eosin pictures of wild-type and Hesx1Cre/+;Apcfl/fl pituitaries, and Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitary tumours. Note that the Apc-deficient pituitary is enlarged but no tumours are apparent and it is histologically normal. The age of the mice is indicated in weeks. Scale bar: 1 mm. b Double immunostaining revealing the expression of p21, phospho-IκBα and phospho-DNA-PKcs in the β-catenin-accumulating clusters, indicating cell cycle inhibition and activation of the NFκB and DNA damage response pathways, in both Hesx1Cre/+;Apcfl/fl and Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries at 18.5 dpc. Note that the clusters are smaller in the Hesx1Cre/+;Apcfl/fl compared with the Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries. Scale bar: 50 μm. c qRT-PCR analysis showing the relative expression of several genes in Hesx1Cre/+;Apcfl/fl relative to Hesx1Cre/+; Ctnnb1lox(ex3)/+ pituitaries at 18.5 dpc. The expression of the WNT pathway targets Axin2 and Lef1 are similar between the two genotypes, but several senescence and SASP factors show reduced expression levels in the Hesx1Cre/+;Apcfl/fl compared with the Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries. Bars represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. *p < 0.05, **p < 0.01, Student’s t test. d In situ hybridisation on histological sections of embryos at 14.5 dpc showing the expression of Axin2 in small cell clusters and very reduced or absent detection of Bmp4, Fgf3 and Shh in the Apc-deficient pituitaries. Scale bar: 100 μm. e Triple immunostaining revealing the expression of β-catenin, SOX9 and EMCN. Note that the large areas of EMCN+;SOX9+ cells surrounding the β-catenin-accumulating clusters are not present in the Hesx1Cre/+;Apcfl/fl pituitaries. Scale bar: 50 μm. f Quantification of the EMCN+ areas demonstrating that wild-type and Apc-deficient pituitaries show similar levels, which are significantly increased in the Hesx1Cre/+;Ctnnb1lox(ex3)/+ pituitaries. Bars represent the mean, and error bars represent standard error of the mean (SEM) of three biological replicates. ***p < 0.001, one-way ANOVA. All results are representative of at least three biological replicatesCC BY · PubMed Central
Fig. 8 Schematic summary of the main findings of this research. a Targeting Sox2+ stem cells from young adults, or Hesx1+ embryonic precursors to express oncogenic β-catenin, results in formation of senescent cell clusters and a robust SASP. This leads to cell transformation and generation of the cell-of-origin of the paracrine tumours, thus the tumours are not derived from the mutation-sustaining cells. b In contrast, the expression of oncogenic β-catenin in Sox2+ stem cells of older mice leads to a reduced tumour incidence or the failure to produce tumours. In addition, upregulation of the WNT pathway through the deletion of Apc in young adult stem cells or embryonic precursors also fails to induce tumours. In all cases described in b, there is attenuated senescence and SASP activation
Fig. 8 Schematic summary of the main findings of this research. a Targeting Sox2+ stem cells from young adults, or Hesx1+ embryonic precursors to express oncogenic β-catenin, results in formation of senescent cell clusters and a robust SASP. This leads to cell transformation and generation of the cell-of-origin of the paracrine tumours, thus the tumours are not derived from the mutation-sustaining cells. b In contrast, the expression of oncogenic β-catenin in Sox2+ stem cells of older mice leads to a reduced tumour incidence or the failure to produce tumours. In addition, upregulation of the WNT pathway through the deletion of Apc in young adult stem cells or embryonic precursors also fails to induce tumours. In all cases described in b, there is attenuated senescence and SASP activationCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 137

Metadata

Authors
Gonzalez-Meljem, J. M., Haston, S., Carreno, G., Apps, J. R., Pozzi, S., Stache, C., Kaushal, G., Virasami, A., Panousopoulos, L., Mousavy-Gharavy, S. N., Guerrero, A., Rashid, M., Jani, N., Goding, C. R., Jacques, T. S., Adams, D. J., Gil, J., Andoniadou, C. L., & Martinez-Barbera, J. P.
Affiliations
  • University College London (GB)
  • Great Ormond Street Hospital (GB)
  • Imperial College London (GB)
  • Wellcome Sanger Institute (GB)
  • University of Oxford (GB)
  • Guy's Hospital (GB)
Venue
Nature Communications
Published
2017-11-28
Volume
8
Issue
1
Pages
1819-1819
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2768478289
Cited by
130
References
70
Citations by year
2026: 9 · 2025: 17 · 2024: 26 · 2023: 16 · 2022: 16 · 2021: 11 · 2020: 17 · 2019: 9 · 2018: 9
FWCI
7.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Wellcome Trust
  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
  • Cancer Research UK (13031, S_1731)
  • National Institute for Health and Care Research
  • University College London
  • CHILDREN with CANCER UK (15/190, W1055)
  • Consejo Nacional de Ciencia y Tecnología
  • Great Ormond Street Hospital for Children
  • University of California, Los Angeles
  • Medical Research Council (MR/M000125/1, MR/L016729/1)
  • National Cancer Institute (P01CA128814)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
stem cell senescence, senescence-associated secretory phenotype, pituitary tumors, adamantinomatous craniopharyngioma, β-catenin, HESX1, cell transformation
MeSH terms
Exome Sequencing, Aniline Compounds, Animals, Biphenyl Compounds, Cell Transformation, Neoplastic, Child, Craniopharyngioma, Disease Models, Animal, Humans, Nitrophenols, Oncogenes, Piperazines, Pituitary Gland, Pituitary Neoplasms, Repressor Proteins, Sulfonamides, Neoplastic Stem Cells, Cellular Senescence, Homeodomain Proteins, beta Catenin, Mice, SOXB1 Transcription Factors, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma. https://app.cochat.ai/papers/10.1038/s41467-017-01992-5
The paper
Gonzalez-Meljem, J. M., Haston, S., Carreno, G., Apps, J. R., Pozzi, S., Stache, C., Kaushal, G., Virasami, A., Panousopoulos, L., Mousavy-Gharavy, S. N., Guerrero, A., Rashid, M., Jani, N., Goding, C. R., Jacques, T. S., Adams, D. J., Gil, J., Andoniadou, C. L., & Martinez-Barbera, J. P. (2017). Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma. Nature Communications. https://doi.org/10.1038/s41467-017-01992-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.